Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
VRDN
$18.34
+0.33%
VRDN
· Viridian Therapeutics, Inc.\DE
$18.34
+0.06 (+0.33%)
At close · Oct 8
Return incl. dividend (before tax)
Market Cap
$2.07B
Shares
113.29M
Volume · Oct 8
2.44M
Avg daily vol (3M)
1.71M
All webcasts
Earnings call · FY2023 Q3
Viridian Therapeutics, Inc.\DE (VRDN) Q3 2023 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$72,000
-94% YoY
Diluted EPS
-$1.09
Net income
-$47.66M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 13, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 13, 2023 · complete as-filed document